Sustained Therapeutics is a platform that allows the production of sustained-release formulations of generic drugs.

Preliminary data from the lead candidate (ST-01) from a completed Phase I clinical trials for the treatment of chronic scrotal pain demonstrated sustained pain relief over a period of up to four weeks with a single injection.